Boehringer Ingelheim Pharmaceuticals, Inc. recalls
2 federal recalls on file, showing the 1 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for Boehringer Ingelheim Pharmaceuticals, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-07-08FDA-DrugClass IISynjardy XR tablets recalled for manufacturing deviation
Boehringer Ingelheim Pharmaceuticals is recalling one lot of Synjardy XR 12.5/1000 mg tablets due to manufacturing quality control issues. During production, an incorrect cleaning agent was used on equipment, and required testing of that equipment was not completed before the tablets were made.
Get the week's recalls, including Boehringer Ingelheim Pharmaceuticals, Inc.
Free weekly digest — every federal recall affecting your household, Boehringer Ingelheim Pharmaceuticals, Inc. included when it comes up. Track Boehringer Ingelheim Pharmaceuticals, Inc. specifically with Always-on.